SREBF1 and colorectal cancer: In our findings, DFS analyses demonstrated consistent associations between elevated expression of cholesterol synthesis markers, SREBP‐1, SQLE, and SOAT1, and poorer outcomes, particularly in breast and colorectal cancers.